Short Course Low Dose Oral Colchicine After ST Elevation Myocardial Infarction(STEMI)

Inclusion Criteria: 1. Age between 18 years to 80 years old 2. STEMI within 24 hours of admission to Pusat Perubatan UKM \& undergoing revascularization therapy (percutaneous coronary intervention) during admission STEMI is diagnosed when there is: * ST elevation of ≥1 mm in 2 contiguous leads or * a new onset LBBB in the resting ECG * in a patient with ischaemic type chest pains of \> 30 minutes and * accompanied by a rise and fall in cardiac biomarkers (CPG MALAYSIA STEMI 2019, 4th Edition) Exclusion Criteria: 1. Pre-existing severe heart failure with left ventricular ejection fraction less than 35% 2. Clinically unstable (Intubated or double inotropic support) 3. Refuse or not suitable for cardiac revascularization therapy 4. Anaemia induced Angina (Hb \< 9 g/dL) 5. Ongoing sepsis requiring antibiotic 6. Ongoing diarrhea (Loose stool 3 times or more per day - stool consistency Bristol chart type 6 \& 7) 7. Active Covid-19 Infection (\< 7 days for Category 1-3, \< 10 days for category 4-5) 8. Stroke within previous 3 months 9. Coronary bypass surgery either within the previous 3 years or planned 10. Active malignancy or treated malignancy within 7 years 11. Active Inflammatory bowel disease on treatment 12. Active Neuromuscular disease on treatment 13. Chronic kidney disease (CKD stage 4 - eGFR \< 30 mL/min/1.73 m2) 14. Severe hepatic disease (ALT \> 3X upper limit normal, Bilirubin \> 2X upper limit normal) 15. Active drug or alcohol abuse on therapy 16. On long term or recent systemic glucocorticoid therapy within 3 months 17. Pregnancy or breastfeeding 18. Known sensitivity to colchicine or multivitamin tablet 19. Pre-existing indication for colchicine therapy (Gout, Familial Mediterranean fever, etc) 20. Patients on oral medications that may interact with colchicine (Clarithromycin, Ketoconazole, Voriconazole, Fluconazole, Itraconazole, Cyclosporine, Ritonavir)